FDA Approves New Drug Tirzepatide for People with Type 2 Diabetes
The Food and Drug Administration (FDA) has approved trusted Source a new drug for people with type 2 diabetes.
In past clinical trials trusted Sources, the drug tripeptide improved glycemic control and assisted with weight loss in people with type 2 diabetes.
“Tirzepatide showed robust improvements in glycemic control and body weight, without increased risk of hypoglycemia,” the researchers wrote.
Read more...